Novo Nordisk
NVO
640 hedge funds and large institutions have $9.91B invested in Novo Nordisk in 2019 Q4 according to their latest regulatory filings, with 119 funds opening new positions, 182 increasing their positions, 221 reducing their positions, and 33 closing their positions.
261% more first-time investments, than exits
New positions opened: 119 | Existing positions closed: 33
216% more call options, than puts
Call options by funds: $94.7M | Put options by funds: $30M
44% more funds holding in top 10
Funds holding in top 10: 9 → 13 (+4)
13% more funds holding
Funds holding: 564 → 640 (+76)
11% more capital invested
Capital invested by funds: $8.89B → $9.91B (+$1.01B)
0.06% less ownership
Funds ownership: 7.57% → 7.5% (-0.06%)
18% less repeat investments, than reductions
Existing positions increased: 182 | Existing positions reduced: 221
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
+$79.2M |
| 2 |
First Trust Advisors
Wheaton,
Illinois
|
+$46.1M |
| 3 |
Loomis, Sayles & Company
Boston,
Massachusetts
|
+$40.5M |
| 4 |
Capital International Investors
Los Angeles,
California
|
+$30.9M |
| 5 |
AAMU
Amundi Asset Management US
Boston,
Massachusetts
|
+$25.1M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
-$192M |
| 2 |
SGA
Sustainable Growth Advisers
Stamford,
Connecticut
|
-$64.7M |
| 3 |
Bank of America
Charlotte,
North Carolina
|
-$44.5M |
| 4 |
CCM
Camber Capital Management
Boston,
Massachusetts
|
-$36.2M |
| 5 |
Adage Capital Partners
Boston,
Massachusetts
|
-$16.6M |
NVO Hedge Fund Activity: Q4 2019 in Review
640 of the 5,092 institutional investors tracked by Wall St. Rank reported a position in Novo Nordisk (NVO) for Q4 2019, worth a combined $9.91B — up 11% from $8.89B a quarter earlier.
Buyers outnumbered sellers: 119 funds opened new NVO positions and 33 closed out — a net gain of 86 holders — while 182 added to existing stakes and 221 trimmed.
The largest buyer was Renaissance Technologies, adding an estimated $79.2M. The largest seller was BlackRock, cutting an estimated $192M.
- 640 institutional investors held Novo Nordisk (NVO) as of Q4 2019, up from 564 in Q3 2019.
- Funds reported $9.91B of Novo Nordisk stock for Q4 2019, up 11% quarter-over-quarter.
- 119 funds opened new Novo Nordisk positions in Q4 2019 and 33 closed out, a net change of +86 holders.
- The largest Novo Nordisk buyer in Q4 2019 was Renaissance Technologies, an estimated $79.2M added.
- The largest Novo Nordisk seller in Q4 2019 was BlackRock, an estimated $192M sold.
Based on aggregated 13F filings for Q4 2019.